Dispenser for delivering drug to livestock

• US 4,927,633 A
• Filed: 06/24/1987
• Issued: 05/22/1990
• Est. Priority Date: 03/19/1984
• Status: Expired due to Term

• Current Assignee: ALZA Corporation (Johnson & Johnson)
• Original Assignee: ALZA Corporation (Johnson & Johnson)
• Inventors: Landrau, Felix A., Eckenhoff, James B., Cortese, Richard
• Primary Examiner(s): Kight, III, John
• Assistant Examiner(s): Nutter, Nathan M.
• Application Number:
  US07/066,674
• Time in Patent Office: 1,063 Days
• Field of Search: 514/30, 514/53, 536/7.1, 424/162, 424/164, 424/438, 604/492.1
• US Class Current: 424/438
• CPC Class Codes: A61K 9/0004 Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
• CPC Class Codes: A61K 9/0068 Rumen, e.g. rumen bolus
• CPC Class Codes: A61M 31/002 Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time artificial gland structures or devices A61F2/022; intra-uterine contraceptive devices A61F6/14; tampons for introducing into the vagina A61F13/20, A61L15/00; suppositories or bougies for intra-vaginal or intra-uterine application A61K9/02; physical forms of medicinal preparations for sustained or differential drug release A61K9/20, A61K9/50

Abstract

A dispensing device is disclosed for delivering a beneficial agent. The device comprises (1) a housing defining an internal space, (2) heat responsive means containing a beneficial agent in the spece, (3) means for increasing the amount of beneficial agent delivered from the device in the space, (4) expandable means in the space, (5) an optional dense means in the space, and (6) means in the housing for delivering the beneficial agent from the dispensing device.

Claims

1. A dispensing device for delivering a beneficial agent formulation to an environment of use, the dispensing device comprising

(a) a wall that defines an internal space, said wall comprising in at least a part a composition that permits the passage of fluid;

(b) a beneficial agent formulation in the space, said formulation comprising selenium;

(c) an expandable composition in the space for urging the beneficial agent formulation from the device;

(d) a layer of a composition comprising means for maintaining the identity of the beneficial agent formulation and the expandable composition in the space between the beneficial agent formulation and the expandable composition;

(e) a density member in the space comprising a density for maintaining the device in the environment of use; and

(f) exit means in the wall for dispensing the beneficial selenium to the environment of use over time.

2. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 1, wherein the selenium is a member selected from the group consisting of selenium disulfide and sodium selenite.

3. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 1, wherein the wall composition comprises cellulose acetate butyrate and cellulose acetate.

4. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 1, wherein the wall comprises cellulose acetate butyrate, cellulose acetate, tributyl citrate, triethyl citrate, and polyethylene glycol.

5. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 1, wherein the expandable composition comprises a member selected from the group consisting of carboxymethylcellulose and sodium carboxymethylcellulose.

6. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 1, wherein the expandable composition comprises sodium carboxymethylcellulose and sodium chloride.

7. A dispensing device for delivering a beneficial agent formulation to an environment of use, the dispensing device comprising:

(a) a wall that defines an internal space, said wall comprising in at least a part a composition that permits the passage of fluid;

(b) a beneficial agent formulation in the space, said formulation comprising selenium;

(c) an expandable composition in the space for urging the beneficial agent formulation from the device, said expandable composition comprising a carboxyvinyl polymer;

(d) a layer of a composition comprising means for maintaining the identity of the beneficial agent formulation and the expandable composition in the space between the beneficial agent formulation and the expandable composition;

(e) a density member in the space comprising a density for maintaining the device in the environment of use; and

(f) exit means in the wall for dispensing the beneficial selenium to the environment of use over time.

8. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 7, wherein the selenium is a member selected from the group consisting of selenium, selenium disulfide and sodium selenite.

9. A dispensing device for delivering the beneficial agent formulation to an environment of use according to claim 7, wherein the wall comprises cellulose acetate butyrate and cellulose acetate.

10. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 7, wherein the wall comprises cellulose acetate butyrate, cellulose acetate, tributyl citrate, triethyl citrate and polyethylene glycol.

11. The dispensing device for delivering the beneficial agent to the environment of use according to claim 7, wherein the exit means comprises a plurality of pores.

12. A dispensing device for delivering a beneficial agent formulation to an environment of use the dispensing device comprising:

(a) a wall that defines an internal space, said wall comprising in at least a part a composition that permits the passage of fluid;

(b) a beneficial agent formulation in the space, said formulation comprising avermectin;

(c) an expandable composition in the space for urging the beneficial agent formulation from the device;

(d) a layer of a composition comprising means for maintaining the identity of the beneficial agent formulation and the expandable composition in the space between the beneficial agent formulation and the expandable composition;

(e) a density member in the space comprising a density for maintaining the device in the environment of use; and

(f) exit means in the wall for dispensing the beneficial avermectin to the environment of use over time.

13. A dispensing device for delivering the beneficial agent formulation to an environment of use according to claim 12, wherein the wall comprises cellulose acetate butyrate and cellulose acetate.

14. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 12, wherein the wall comprises cellulose acetate butyrate, cellulose acetate, tributyl citate, triethyl citrate, and polyethylene glycol.

15. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 12 wherein the expandable composition comprises a member selected from the group consisting of carboxymethylcellulose and sodium carboxymethylcellulose.

16. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 12, wherein the expandable member comprises sodium carboxymethylcellulose and sodium chloride.

17. The dispensing device for delivering the beneficial agent to the environment of use according to claim 12, wherein the exit means comprises a plurality of pores.

18. The dispensing device for delivering the beneficial agent to the environment of use according to claim 12, wherein the avermectin is ivermectin.

19. A dispensing device for delivering a beneficial agent formulation to an environment of use, the dispensing device comprising:

(a) a wall that defines an internal space, said wall comprising in at least a part a composition that permits the passage of fluid;

(b) a beneficial agent formulation in the space, said formulation comprising avermectin;

(c) an expandable composition in the space for urging the beneficial agent formulation from the device, said expandable composition comprising a carboxyvinyl polymer;

(d) a layer of a composition comprising means for maintaining the identity of the beneficial agent formulation and the expandable composition in the space between the beneficial agent formulation and the expandable composition;

(e) a density member in the space comprising a density for maintaining the device in the environment of use; and

(f) exit means in the wall for dispensing the beneficial avermectin to the environment of use over time.

20. A dispensing device for delivering the beneficial agent formulation to an environment of use according to claim 19, wherein the wall comprises cellulose acetate butyrate and cellulose acetate.

21. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 19, wherein the wall comprises cellulose acetate butyrate, cellulose acetate, tributyl citrate, triethyl citrate, and polyethylene glycol.

22. The dispensing device for delivering the beneficial agent formulation according to claim 19, wherein the carboxyvinyl polymer is a carboxypolymethylene polymer.

23. The dispensing device for delivering the beneficial agent formulation according to claim 19, wherein the carboxyvinyl polymer is a polymer of acrylic acid cross-linked with polyallyl sucrose.

24. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 19, wherein the expandable composition comprises carboxyvinyl polymer and sodium chloride.

25. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 19, wherein the expandable composition comprises carboxyvinyl polymer, sodium chloride, and polyvinyl pyrrolidone.

26. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 19, wherein the expandable composition comprises carboxyvinyl polymer, sodium chloride, polyvinyl pyrrolidone, and magnesium stearate.

27. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 19, wherein the exit means comprises a plurality of pores.

28. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 19, wherein the avermectin is ivermectin.

29. A dispensing device for delivering a beneficial agent to an environment of use, the dispensing device comprising:

(a) a wall;

(b) an internal lumen defined by the wall;

(c) a beneficial agent formulation comprising a lasolocid in the lumen;

(d) a composition in the lumen for pushing the beneficial agent formulation from the device;

(e) a density member in the lumen comprising a density for maintaining the device in the environment of use; and

,

(f) exit means in the device for dispensing the beneficial lasolocid to the environment of use over time.

30. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 29, wherein the composition for pushing the beneficial agent formulation comprises a member selected from the group consisting of carboxymethylcellulose, sodium carboxymethylcellulose, a composition comprising carboxymethylcellulose and sodium chloride, a composition comprising a carboxyvinyl polymer, sodium chloride and polyvinyl pyrrolidone, and a composition comprising a carboxyvinyl polymer, sodium chloride, polyvinyl pyrrolidone and magnesium stearate.

31. The dispensing device for delivering the beneficial agent to the environment of use according to claim 29, wherein the wall comprises cellulose acetate butyrate and cellulose acetate.

32. The dispensing device for delivering the beneficial agent to the environment of use according to claim 29, wherein the wall comprises tributyl citrate and triethyl citrate.

33. A dispensing device for delivering a beneficial agent to an environment of use, the dispensing device comprising:

(a) a wall;

(b) an internal lumen defined by the wall;

(c) a beneficial agent comprising an ionophere in the lumen;

(d) means in the lumen for pushing the beneficial ionophere from the device;

(e) means for maintaining the identity of the beneficial ionophere and the means for pushing the ionophere from the device, said means for maintaining the identity in the lumen between the beneficial ionophere and the means for pushing;

(f) a density member in the lumen for maintaining the device in the environment of use; and

,

(g) exit means in the device for dispensing the beneficial ionophere to the environment of use over time.

34. The dispensing device for delivering the beneficial ionophere to the environment of use according to claim 33, wherein the means for pushing comprise a member selected from the group consisting of carboxymethylcellulose, sodium carboxymethylcellulose, a composition comprising carboxymethylcellulose and sodium chloride, a composition comprising a carboxyvinyl polymer, sodium chloride and polyvinyl pyrrolidone, and a composition comprising a carboxyvinyl polymer, sodium chloride, polyvinyl pyrrolidone and magnesium stearate.

35. The dispensing device for delivering the beneficial ionophere to the environment of use according to claim 33, wherein the wall comprises cellulose acetate butyrate and cellulose acetate.

36. The dispensing device for delivering the beneficial ionophere to the environment of use according to claim 33, wherein the wall comprises tributyl citrate and triethyl citrate.

37. The dispensing device for delivering the beneficial ionophere to the environment of use according to claim 33, wherein the ionophere is a member selected from the group consisting of lasalocid, salinomycin, virginiamycin and ronnel.